Free Trial

Ocugen (OCGN) Stock Price, News & Analysis

Ocugen logo
$1.14 -0.01 (-0.87%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$1.14 0.00 (-0.44%)
As of 07/11/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Ocugen Stock (NASDAQ:OCGN)

Key Stats

Today's Range
$1.11
$1.19
50-Day Range
$0.66
$1.20
52-Week Range
$0.52
$1.98
Volume
4.18 million shs
Average Volume
4.59 million shs
Market Capitalization
$332.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Buy

Company Overview

Ocugen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
30th Percentile Overall Score

OCGN MarketRank™: 

Ocugen scored higher than 30% of companies evaluated by MarketBeat, and ranked 779th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ocugen has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Ocugen has only been the subject of 2 research reports in the past 90 days.

  • Read more about Ocugen's stock forecast and price target.
  • Earnings Growth

    Earnings for Ocugen are expected to decrease in the coming year, from ($0.20) to ($0.26) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ocugen is -6.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ocugen is -6.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Ocugen has a P/B Ratio of 11.40. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Ocugen's valuation and earnings.
  • Percentage of Shares Shorted

    22.65% of the float of Ocugen has been sold short.
  • Short Interest Ratio / Days to Cover

    Ocugen has a short interest ratio ("days to cover") of 11.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Ocugen has recently decreased by 3.04%, indicating that investor sentiment is improving.
  • Dividend Yield

    Ocugen does not currently pay a dividend.

  • Dividend Growth

    Ocugen does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    22.65% of the float of Ocugen has been sold short.
  • Short Interest Ratio / Days to Cover

    Ocugen has a short interest ratio ("days to cover") of 11.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Ocugen has recently decreased by 3.04%, indicating that investor sentiment is improving.
  • News Sentiment

    Ocugen has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Ocugen this week, compared to 4 articles on an average week.
  • Search Interest

    16 people have searched for OCGN on MarketBeat in the last 30 days. This is an increase of 23% compared to the previous 30 days.
  • MarketBeat Follows

    Only 6 people have added Ocugen to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Ocugen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.42% of the stock of Ocugen is held by insiders.

  • Percentage Held by Institutions

    Only 10.27% of the stock of Ocugen is held by institutions.

  • Read more about Ocugen's insider trading history.
Receive OCGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ocugen and its competitors with MarketBeat's FREE daily newsletter.

OCGN Stock News Headlines

Ocugen: Three Potential Gene-Therapy Filings By 2028
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Ocugen To Present at BIO International Convention 2025
See More Headlines

OCGN Stock Analysis - Frequently Asked Questions

Ocugen's stock was trading at $0.8050 on January 1st, 2025. Since then, OCGN stock has increased by 41.6% and is now trading at $1.14.

Ocugen, Inc. (NASDAQ:OCGN) announced its earnings results on Friday, May, 9th. The company reported ($0.05) EPS for the quarter, beating analysts' consensus estimates of ($0.06) by $0.01. The company had revenue of $1.48 million for the quarter. Ocugen had a negative trailing twelve-month return on equity of 223.00% and a negative net margin of 1,271.12%.
Read the conference call transcript
.

Top institutional investors of Ocugen include Procyon Advisors LLC (0.07%) and Baader Bank Aktiengesellschaft (0.01%). Insiders that own company stock include Shankar Musunuri, Junge Zhang, Kirsten Castillo, Prabhavathi Fernandes and Ramesh Kumar.
View institutional ownership trends
.

Shares of OCGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ocugen investors own include Zomedica (ZOM), American Water Works (AWK), Waste Connections (WCN), AU Optronics (AUOTY), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and The RMR Group (RMR).

Company Calendar

Last Earnings
5/09/2025
Today
7/12/2025
Next Earnings (Estimated)
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:OCGN
CIK
1372299
Employees
80
Year Founded
N/A

Price Target and Rating

High Price Target
$7.00
Low Price Target
$4.00
Potential Upside/Downside
+426.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$54.05 million
Net Margins
-1,271.12%
Pretax Margin
-1,271.12%
Return on Equity
-223.00%
Return on Assets
-92.20%

Debt

Debt-to-Equity Ratio
1.74
Current Ratio
2.60
Quick Ratio
2.60

Sales & Book Value

Annual Sales
$4.05 million
Price / Sales
82.20
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.10 per share
Price / Book
11.40

Miscellaneous

Outstanding Shares
292,030,000
Free Float
279,123,000
Market Cap
$332.91 million
Optionable
Optionable
Beta
4.18
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:OCGN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners